Analyte Sensor Partner Interface for Interoperable Glucose Data Links
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional systems for managing diabetes through wireless communication of analyte data face challenges in interoperability, flexibility, and adaptability across devices from different manufacturers, particularly in maintaining synchronized analyte data communication and managing devices that regulate blood glucose levels.
Innovation Solution
A diabetes management partner interface is used to configure an analyte sensor system for wireless communication with partner devices, allowing for setting or modifying configuration parameters such as wireless connectivity, access control, and analyte data parameters based on system requirements, including battery capacity, accuracy, communication protocols, and regulatory requirements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional SMBG monitors are used for blood glucose monitoring, then the device structure is simple and easy to manufacture, but the measurement frequency is limited (2-4 times per day) and the timeliness of glucose level information is insufficient
Solution Approach 1:
The patent replaces the mechanical finger-pricking method with a transdermal electrochemical sensor system that uses electrical signals to detect glucose levels continuously through the skin, eliminating the need for repeated mechanical punctures and enabling real-time monitoring without increasing structural complexity significantly
Solution Approach 2:
The patent introduces a remote device as an intermediary that receives analyte data from the sensor system via wireless transmission and provides processed glucose level information to the user, separating the sensing function from the display and processing functions to improve timeliness while managing complexity
2Measurement precision
If implantable sensors are used for continuous analyte detection, then the timeliness of glucose level information is improved, but interoperability issues arise with devices from different manufacturers and regulatory requirements become more stringent
Solution Approach 1:
The patent implements a universal interface architecture that allows the analyte sensor system to communicate with multiple types of partner devices (insulin pumps, CGMs, mobile devices) from different manufacturers through standardized communication protocols, enabling one sensor system to serve multiple functions and integrate with various diabetes management devices
Solution Approach 2:
The patent employs configurable communication parameters that can be adjusted to meet different regulatory requirements and device specifications, allowing the system to adapt its transmission protocols, data formats, and security settings to work seamlessly with partner devices from various manufacturers while maintaining continuous detection capability
3Adaptability or versatility
If multiple partner devices are connected to the analyte sensor system, then the versatility of the system is improved, but the device complexity and difficulty of maintaining synchronized communication increase
Solution Approach 1:
The patent divides the communication management into distinct functional modules: a partner device manager component that handles device pairing and authorization, a data synchronization module that coordinates information exchange, and individual communication interfaces for each device type, reducing the overall complexity by organizing the multi-device communication system into manageable segments
Data Source
AI summary
Systems, devices, and methods are disclosed for wireless communication of analyte data. In embodiments, a method of using a diabetes management partner interface to configure an analyte sensor system for wireless communication with a plurality of partner devices is provided. The method includes the analyte sensor system receiving authorization to provide one of the partner devices with access to a set of configuration parameters via the diabetes management partner interface. The set of configuration parameters is stored in a memory of the analyte sensor system. The method also includes, responsive to input received from the one partner device via the diabetes management partner interface, the analyte sensor system setting or causing a modification to the set of configuration parameters, according to a system requirement of the one partner device.


